Skip to content
healthcare.dev

YESINTEK

NDC 83257-026, ustekinumab, solution, from Biocon Biologics Inc..

Product NDC
83257-026
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761406
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB130 mg/26mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
83257-026-11832570026111 VIAL, SINGLE-USE in 1 BOX (83257-026-11) / 26 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/12a75613-ee33-d30a-215b-2a51cfa19b00
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83257-026

Use it

Look up 83257-026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.